Loading...
Among patients with type 2 diabetes who use insulin, many have difficulty reaching their targets for glycemic control. Barriers to success include the months that usually pass between opportunities for clinicians to titrate insulin doses and the time required to calculate these adjustments and convey them to patients.
In this study from three U.S. diabetes centers, researchers evaluated the effectiveness and safety of a novel system (d-Nav Insulin Guidance System) that measures, records, and analyzes scheduled fingerstick blood glucose levels and uses an algorithm to recommend insulin dose adjustments directly to patients. About 180 patients with type 2 diabetes (age range, 21–70) were randomized to receive usual support from healthcare prof…